BridgeBio Pharma
BBIO
$29.97
Share price
3.52%
Change (1 day)
101.95%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) - Net assets
Net assets on the balance sheet as of March 2024 : -$1.04 B
According to BridgeBio Pharma
's latest financial reports the company has -$1.04 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
BridgeBio Pharma - Net assets on balance sheet (from 2018 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-1.35 B | 7.84% |
| 2022-12-31 | $-1.25 B | 43.83% |
| 2021-12-31 | $-0.87 B | -902.31% |
| 2020-12-31 | $0.10 B | -77.33% |
| 2019-12-31 | $0.47 B | 26.13% |
| 2018-12-31 | $0.37 B | -790.06% |
| 2017-12-31 | $-54.69 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.38 B | -233.98% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $10.67 M | -101.03% | 🇺🇸 USA |